Breaking through the boundaries of Traditional Research

KROMATID provides single-cell genomic and edit integrity insights that reveal insertional mutagenesis risk and comprehensive genotoxicity profiles long before clinical consequences appear. Our platform guides edit optimization by showing exactly how genome engineering impacts each individual cell, enabling safer and more predictable outcomes. We help you start with confidence through rigorous starting material analysis, donor qualification, and deep characterization of primary cells and engineered cell lines. Finally, KROMATID delivers the evidence needed for batch release by confirming genomic stability at the resolution regulators — and patients — actually depend on.